Dr. Zakaria MD's banner
Dr. Zakaria MD's profile picture

Dr. Zakaria MD

@ZakariaMDv351,048 subscribers

Exploring alternative & integrative cancer protocols | Patient stories, research shares, hope & support | Not medical advice. Ivermectin. Oncologist. 💪💪🌿🌿❤️

Shorts

Be sure to take IVERMECTIN HORSE PASTE every Monday & Tuesday - a PEA-SIZE DOSE. The first dose kills the MOTHER WORMS - they emit a hormone that prevents WORM SACKS from hatching - DRS call these TUMORS. SACKS OF WORMS. Once the sacks break, if you go have an X-ray, you are SUDDENLY FREE OF CANCER. OVERNIGHT! CANCER is SACKS OF WORMS. IVERMECTIN HORSE PASTE kills them. The second dose kills the babies that hatched. But you must remember that parasites are in our AIR, WATER, SOIL, FOOD. So you MUST take IVERMECTIN HORSE PASTE every M&T as a routine. A pea-size dose. Or you can simply make sure you include in your diet all the wonderful vegetables & fruits, including WORMWOOD - IVERMECTIN is WORMWOOD & HONEY, natural anti-parasitic mixed with a natural antibiotic. MULTIPLE SCLEROSIS, PARKINSON’S, JOINT PAIN, ARTHRITIS, & 99.9% of ALL ILLNESSES start with VACCINES that weaken the myelin / cholesterol that protects the spinal cord / nervous system / brain. Now WORMS can burrow in & take over. Drs autopsied 10 who died from MS - all had worm holes in the spinal cord & brain! Their is NO WEALTH IN GOOD HEALTH, so the SATANIC PEDOPHILE CABAL DEEP STATE took control of MEDICAL SCHOOLS, OIL FIELDS, & POPPY FIELDS: they MIND-CONTROL us with SUBLIMINAL MESSAGING on TV, RADIO, SPORTS, CASINOS, etc, then put OPIUM & PETROLEUM IN ALL PILLS, CAPSULES, & SYRUPS, IN OUR FOOD, COATING ON OUR PRODUCE, in our AIR & WATER - all to sicken us. Then they PRESCRIBE MORE OF THIS POISON TO KERP US SICK & they MILK EVERY DIME FRIM US, then they KILL US.

Be sure to take IVERMECTIN HORSE PASTE every Monday & Tuesday - a PEA-SIZE DOSE. The first dose kills the MOTHER WORMS - they emit a hormone that prevents WORM SACKS from hatching - DRS call these TUMORS. SACKS OF WORMS. Once the sacks break, if you go have an X-ray, you are SUDDENLY FREE OF CANCER. OVERNIGHT! CANCER is SACKS OF WORMS. IVERMECTIN HORSE PASTE kills them. The second dose kills the babies that hatched. But you must remember that parasites are in our AIR, WATER, SOIL, FOOD. So you MUST take IVERMECTIN HORSE PASTE every M&T as a routine. A pea-size dose. Or you can simply make sure you include in your diet all the wonderful vegetables & fruits, including WORMWOOD - IVERMECTIN is WORMWOOD & HONEY, natural anti-parasitic mixed with a natural antibiotic. MULTIPLE SCLEROSIS, PARKINSON’S, JOINT PAIN, ARTHRITIS, & 99.9% of ALL ILLNESSES start with VACCINES that weaken the myelin / cholesterol that protects the spinal cord / nervous system / brain. Now WORMS can burrow in & take over. Drs autopsied 10 who died from MS - all had worm holes in the spinal cord & brain! Their is NO WEALTH IN GOOD HEALTH, so the SATANIC PEDOPHILE CABAL DEEP STATE took control of MEDICAL SCHOOLS, OIL FIELDS, & POPPY FIELDS: they MIND-CONTROL us with SUBLIMINAL MESSAGING on TV, RADIO, SPORTS, CASINOS, etc, then put OPIUM & PETROLEUM IN ALL PILLS, CAPSULES, & SYRUPS, IN OUR FOOD, COATING ON OUR PRODUCE, in our AIR & WATER - all to sicken us. Then they PRESCRIBE MORE OF THIS POISON TO KERP US SICK & they MILK EVERY DIME FRIM US, then they KILL US.

123,846 views

🚨 IVERMECTIN and FENBENDAZOLE Testimonial 53-Year-Old Utah Woman with Stage 4 Breast Cancer Reaches Remission in 11 Months Trigger Warning: No chemotherapy, no immunotherapy, no targeted therapy, and no hormone therapy. Only palliative radiation was used on a few painful bone spots before starting the alternative protocol. A 53-year-old woman from Utah was diagnosed with Stage 4 breast cancer. For 11 months, she followed this protocol: • Ivermectin: 60 mg/day (~1 mg/kg) • Fenbendazole: 222 mg with MCT oil or other healthy fats (5 days on, 2 days off) • Ketogenic diet For the complete protocol, refer to the source. “Thank you for your vocal endorsement of alternative cancer treatments. It is partly because of your voice that a friend/patient has achieved these results.” “She had Stage 4 metastatic breast cancer and, within 11 months, was essentially cancer-free based on her PET scan.” “Her results are almost miraculous.” No chemotherapy. No immunotherapy. No targeted therapy. No hormone therapy. Source: Oncology guidelines and clinical research standards

🚨 IVERMECTIN and FENBENDAZOLE Testimonial 53-Year-Old Utah Woman with Stage 4 Breast Cancer Reaches Remission in 11 Months Trigger Warning: No chemotherapy, no immunotherapy, no targeted therapy, and no hormone therapy. Only palliative radiation was used on a few painful bone spots before starting the alternative protocol. A 53-year-old woman from Utah was diagnosed with Stage 4 breast cancer. For 11 months, she followed this protocol: • Ivermectin: 60 mg/day (~1 mg/kg) • Fenbendazole: 222 mg with MCT oil or other healthy fats (5 days on, 2 days off) • Ketogenic diet For the complete protocol, refer to the source. “Thank you for your vocal endorsement of alternative cancer treatments. It is partly because of your voice that a friend/patient has achieved these results.” “She had Stage 4 metastatic breast cancer and, within 11 months, was essentially cancer-free based on her PET scan.” “Her results are almost miraculous.” No chemotherapy. No immunotherapy. No targeted therapy. No hormone therapy. Source: Oncology guidelines and clinical research standards

23,629 views

Videos

ZakariaMDv3's profile picture

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Dr. Zakaria MD

46,717 views • 1 month ago

ZakariaMDv3's profile picture

Ivermectin and Fenbendazole keep coming up in studies. Not the first story I've heard. Probably not the last. But here's what I've learned – from personal experience and from watching others. The Dosage (Simple Rule) If you're taking the paste – no more than the size of your pinky nail per day. Take it for several days, then take a break for a week. Got something chronic? Get advice first. My Experience I was sick in 2023. Took a small dose. The colour came back to my face in one day. Not a miracle. Just a real response. I've also seen viruses improve fast. People I know – really sick – had good results. The Cat, The Cancer, and The Missed Chance I wish I had tried this with my cat, Sam. He had cancer. The vets had no answers. The dose would have been tiny – less than a milligram, based on weight. But I didn't know then what I know now. Why Was It Stopped? It was used routinely. Until Covid. Then suddenly, availability disappeared. You gotta wonder why. Meanwhile, Ivermectin won a Nobel Prize in 2015. And arthritis and cancer share similar inflammatory pathways – Ivermectin has been shown to help both. Be Smart. Be Careful. I'm not a doctor. I recommend talking to NZDSOS – New Zealand Doctors Speaking Out with Science. A body I trust. Find the studies. Keep the dose small. Talk to people who've had good results. One More Thing The problem? They can't make money on a cheap, generic drug. So they don't study it. So they don't promote it.

Dr. Zakaria MD

13,684 views • 18 days ago

ZakariaMDv3's profile picture

Ivermectin and Mebendazole in Cancer Patients The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Overall, it is estimated that annual costs of standard chemotherapies average $111,000 per year. Background: Drug repurposing offers a pathway to identify accessible, low-toxicity cancer therapies. Ivermectin and mebendazole have demonstrated multi-target anti-cancer activity. This paper evaluates real-world patient-reported outcomes, safety, and adherence in a cohort of cancer patients utilizing this combination protocol. Methods: Prospective observational cohort of 197 cancer patients, who were prescribed ivermectin and mebendazole off-label through telemedicine (platform by licensed U.S. healthcare providers) Participants received compounded oral capsules containing 25 mg ivermectin and 250 mg mebendazole. Data were collected via voluntary, standardized digital surveys at baseline and at approximately 6-month follow-up. Of the initial cohort (N = 197), baseline characteristics, including cancer type and disease status, were assessed. A total of 122 participants completed the follow-up survey (61.9% response rate) Results: Mean age of 67 years, (52.3% male, 47.7% female). Cancer types included Prostate 27.9% Breast 18.3% Lung 8.6% Colon 5.1% Urologic 4.6% Pancreatic 3.0% Liver 2.5% Gynaecologic 2.5% Hematologic 2.5% Median duration since initial diagnosis, 1.2 years 37.1% experiencing active disease progression. 6-month follow-up Medication adherence, 86.9% Full initial 90-capsule ivermectin-mebendazole prescription. The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Notably, 48.4% of cohort, strongest positive outcomes: Regression, 15.6% No current evidence of disease (NED), 32.8% Disease stability, 36.1% Disease progression, 15.6% No significant dose-response association was observed for cancer outcomes (p = 0.91), without a clear dose-response gradient for efficacy. Side effects Mild side effects (primarily gastrointestinal), 25.4% (93.6% of those affected continued treatment through minor dose adjustments) Concurrent conventional therapies Chemotherapy, 27.9% Radiation therapy, 21.3% Surgery, 19.7% Adjunctive interventions such as supplement use, 49.2% Dietary modification, 37.7% Conclusions: In this prospective real-world cohort, the combination of ivermectin and mebendazole was associated with high rates of self-reported clinical benefit, with nearly half of participants reporting tumours regression or no current evidence of disease across a heterogeneous population of cancer patients. These findings provide a compelling clinical signal that these well-tolerated, repurposed agents may offer therapeutic benefit. However, observational design, reliance on self-reported outcomes, and potential for selection bias and uncontrolled confounding, these findings should be interpreted as hypothesis-generating. Urgent prospective, randomized, placebo-controlled clinical trials Validate these observations and further define optimal dosing strategies. Mechanism (pharmacodynamics) Ivermectin and mebendazole are antiparasitic agents, demonstrated highly promising anti-cancer activity. Ivermectin Shown to exert over 14 distinct anti-cancer mechanisms across more than 12 cancer types, inhibiting cancer cell proliferation, metastasis, angiogenesis, mitochondrial function. Has demonstrated excellent safety in cancer patients (including those actively undergoing chemotherapy) Ivermectin and mebendazole selectively target cancer stem cells Mebendazole Microtubule disruption, leading to effective cell cycle arrest Potent induction of apoptosis Significant inhibition of tumour growth Inhibition of angiogenesis Disruption of glucose uptake When used together Target non-overlapping pathways, resulting in synergistic tumour regression, cancer stem cell depletion, and reversal of multidrug resistance in multiple in vitro and in vivo models Biodistribution, ivermectin and mebendazole document excellent tissue penetration

Dr. Zakaria MD

10,766 views • 1 month ago